发明名称 NOVEL PIPERIDINE COMPOUND OR SALT THEREOF
摘要 A novel compound which has an excellent aurora A-selective inhibitory action and is useful as an orally administrable anticancer agent is provided. Also, a novel agent for potentiation of anti-tumor effect of microtubule agonists, which include a taxane anticancer agent, and a combination therapy are provided. A piperidine compound represented by a general formula (I) or a salt thereof: wherein, R 1 represents a carboxyl group, -C(=O)NR 5 R 6 , or an oxadiazolyl group optionally having a C 1 -C 6 alkyl group or a trifluoromethyl group as a substituent; R 2 represents a halogen atom or a C 1 -C 6 alkoxy group; R 3 represents a phenyl group optionally having 1 to 3 same or different group(s) selected from a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, and a trifluoromethyl group as a substituent; R 4 represents a hydrogen atom or a C 1 -C 6 alkyl group; and R 5 and R 6 are the same or different and each represent a hydrogen atom, a C 1 -C 6 alkyl group, or a C 3 -C 6 cycloalkyl group, or R 5 and R 6 optionally form a 3 to 6-membered nitrogen-containing saturated heterocyclic group together with a nitrogen atom to which R 5 and R 6 are bound, are provided.
申请公布号 EP2821406(A1) 申请公布日期 2015.01.07
申请号 EP20130755229 申请日期 2013.02.27
申请人 TAIHO PHARMACEUTICAL CO., LTD. 发明人 SUGIMOTO, TETSUYA;TAKAHASHI, HIDEKAZU;MITSUYA, MORIHIRO;MASUKO, NORIO;SOOTOME, HIROSHI
分类号 C07D401/14;A61K31/337;A61K31/4545;A61P1/04;A61P1/16;A61P1/18;A61P11/00;A61P13/08;A61P13/10;A61P13/12;A61P15/00;A61P17/00;A61P19/00;A61P21/00;A61P25/00;A61P35/00;A61P35/02;A61P43/00;C07D413/14;C07D417/14 主分类号 C07D401/14
代理机构 代理人
主权项
地址